{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:00:20Z","timestamp":1774551620670,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001445","name":"Alex's Lemonade Stand Foundation for Childhood Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jpeds.2019.05.051","type":"journal-article","created":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T01:55:35Z","timestamp":1561168535000},"page":"195-200.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Development of the Serum \u03b1-Fetoprotein Reference Range in Patients with Beckwith-Wiedemann Spectrum"],"prefix":"10.1016","volume":"212","author":[{"given":"Kelly A.","family":"Duffy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okan U.","family":"Elci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Kalish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2019.05.051_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrendo.2017.166","article-title":"Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement","volume":"14","author":"Brioude","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jpeds.2019.05.051_bib2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/GIM.0b013e31819436cf","article-title":"Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia","volume":"11","author":"Clericuzio","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2019.05.051_bib3","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/ajmg.a.38266","article-title":"Nomenclature and definition in asymmetric regional body overgrowth","volume":"173","author":"Kalish","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2019.05.051_bib4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0022-3476(98)70008-3","article-title":"Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry","volume":"132","author":"DeBaun","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2019.05.051_bib5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/pbc.24215","article-title":"The epidemiology of hepatoblastoma","volume":"59","author":"Spector","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2019.05.051_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/088800101750059828","article-title":"Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood","volume":"18","author":"Schneider","year":"2001","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2019.05.051_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cccn.2004.06.020","article-title":"Alpha-fetoprotein in the early neonatal period\u2014a large study and review of the literature","volume":"349","author":"Bader","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jpeds.2019.05.051_bib8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/hpb.12112","article-title":"Predictors of survival and incidence of hepatoblastoma in the paediatric population","volume":"15","author":"Allan","year":"2013","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jpeds.2019.05.051_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MOP.0000000000000046","article-title":"Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy","volume":"26","author":"Czauderna","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jpeds.2019.05.051_bib10","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1158\/1078-0432.CCR-17-0710","article-title":"Surveillance recommendations for children with overgrowth syndromes and predisposition to Wilms tumors and hepatoblastoma","volume":"23","author":"Kalish","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jpeds.2019.05.051_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.sempedsurg.2011.10.011","article-title":"Hepatoblastoma: recent developments in research and treatment","volume":"21","author":"von Schweinitz","year":"2012","journal-title":"Semin Pediatr Surg"},{"key":"10.1016\/j.jpeds.2019.05.051_bib12","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/clinchem\/44.12.2548","article-title":"Serum alpha-fetoprotein in newborns","volume":"44","author":"Bellini","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.jpeds.2019.05.051_bib13","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1373\/clinchem.2014.229799","article-title":"Pediatric population reference value distributions for cancer biomarkers and covariate-stratified reference intervals in the CALIPER cohort","volume":"60","author":"Bevilacqua","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.jpeds.2019.05.051_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/adc.62.4.362","article-title":"Plasma alpha fetoprotein reference ranges in infancy: effect of prematurity","volume":"62","author":"Blair","year":"1987","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2019.05.051_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/08880019809167228","article-title":"Alpha 1-fetoprotein (AFP) reference values in infants up to 2 years of age","volume":"15","author":"Blohm","year":"1998","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2019.05.051_bib16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0002-9378(77)90494-X","article-title":"Serum alpha-fetoprotein in adults, in women during pregnancy, in children at birth, and during the first week of life: a sex difference","volume":"127","author":"Caballero","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jpeds.2019.05.051_bib17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0022-3476(73)80116-7","article-title":"Influence of gestational age on serum levels of alpha-1 fetoprotein, IgG globulin, and albumin in newborn infants","volume":"82","author":"Hyvarinen","year":"1973","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2019.05.051_bib18","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.cca.2011.05.027","article-title":"Pediatric reference intervals for serum alpha-fetoprotein","volume":"412","author":"La'ulu","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jpeds.2019.05.051_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0022-3476(05)80501-3","article-title":"Biphasic reduction and concanavalin A binding properties of serum alpha-fetoprotein in preterm and term infants","volume":"118","author":"Lahdenne","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2019.05.051_bib20","first-page":"19","article-title":"Serum alpha-fetoprotein levels in normal infants: a reappraisal of regression analysis and sex difference","volume":"8","author":"Lee","year":"1989","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jpeds.2019.05.051_bib21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0338-4535(84)80131-2","article-title":"Recent data on alphafetoprotein","volume":"27","author":"Masseyeff","year":"1984","journal-title":"Rev Fr Transfus Immunohematol"},{"key":"10.1016\/j.jpeds.2019.05.051_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-2008-1071168","article-title":"Alpha-fetoprotein (AFP) levels in normal children","volume":"7","author":"Ohama","year":"1997","journal-title":"Eur J Pediatr Surg"},{"key":"10.1016\/j.jpeds.2019.05.051_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1542\/pir.32.7.306","article-title":"Tumor markers in infancy and childhood","volume":"32","author":"Ricafort","year":"2011","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.jpeds.2019.05.051_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0971-5851.56328","article-title":"Tumor markers in clinical practice: general principles and guidelines","volume":"30","author":"Sharma","year":"2009","journal-title":"Indian J Med Paediatr Oncol"},{"key":"10.1016\/j.jpeds.2019.05.051_bib25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.clinbiochem.2008.04.025","article-title":"IMMULITE 2000 age and sex-specific reference intervals for alpha fetoprotein, homocysteine, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein-3, C-peptide, immunoglobulin E and intact parathyroid hormone","volume":"41","author":"Soldin","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jpeds.2019.05.051_bib26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1203\/00006450-198101000-00012","article-title":"Serum alpha fetoprotein (AFP) levels in normal infants","volume":"15","author":"Wu","year":"1981","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jpeds.2019.05.051_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1067\/mpd.2000.106217","article-title":"Serum alpha-fetoprotein levels in Beckwith-Wiedemann syndrome","volume":"137","author":"Everman","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2019.05.051_bib28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ajmg.a.38068","article-title":"The utility of alpha-fetoprotein screening in Beckwith-Wiedemann syndrome","volume":"173","author":"Duffy","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2019.05.051_bib29","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/ajmg.a.37881","article-title":"Tumor screening in Beckwith-Wiedemann syndrome\u2014to screen or not to screen?","volume":"170","author":"Kalish","year":"2016","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2019.05.051_bib30","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/ajmg.a.37801","article-title":"Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups","volume":"170","author":"Maas","year":"2016","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2019.05.051_bib31","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ajmg.a.38077","article-title":"Serum alpha-fetoprotein screening for hepatoblastoma in Beckwith-Wiedemann syndrome","volume":"173","author":"Mussa","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2019.05.051_bib32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1634\/theoncologist.5-6-445","article-title":"Childhood cancers: hepatoblastoma","volume":"5","author":"Herzog","year":"2000","journal-title":"Oncologist"},{"key":"10.1016\/j.jpeds.2019.05.051_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-3468(78)80010-4","article-title":"Evaluation of alpha-fetoprotein in early infancy","volume":"13","author":"Tsuchida","year":"1978","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpeds.2019.05.051_bib34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000355544","article-title":"Beckwith-Wiedemann syndrome: growth pattern and tumor risk according to molecular mechanism, and guidelines for tumor surveillance","volume":"80","author":"Brioude","year":"2013","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.jpeds.2019.05.051_bib35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejmg.2015.11.008","article-title":"Recommendations of the Scientific Committee of the Italian Beckwith-Wiedemann Syndrome Association on the diagnosis, management and follow-up of the syndrome","volume":"59","author":"Mussa","year":"2016","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.jpeds.2019.05.051_bib36","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/MPH.0000000000000408","article-title":"Screening hepatoblastoma in Beckwith-Wiedemann syndrome: a complex issue","volume":"37","author":"Mussa","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2019.05.051_bib37","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/ajmg.a.32966","article-title":"Experience with hemihyperplasia and Beckwith-Wiedemann syndrome surveillance protocol","volume":"149A","author":"Zarate","year":"2009","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jpeds.2019.05.051_bib38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3476(98)70001-0","article-title":"Children at increased risk for Wilms tumor: monitoring issues","volume":"132","author":"Beckwith","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2019.05.051_bib39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1440-1754.2006.00908.x","article-title":"Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice","volume":"42","author":"Tan","year":"2006","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jpeds.2019.05.051_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00431-010-1377-2","article-title":"Educational paper: screening in cancer predisposition syndromes: guidelines for the general pediatrician","volume":"170","author":"Teplick","year":"2011","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jpeds.2019.05.051_bib41","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s10897-017-0182-8","article-title":"Tumor screening in Beckwith-Wiedemann syndrome: parental perspectives","volume":"27","author":"Duffy","year":"2018","journal-title":"J Genet Couns"},{"key":"10.1016\/j.jpeds.2019.05.051_bib42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1067\/S0022-3476(03)00306-8","article-title":"Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia","volume":"143","author":"Clericuzio","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2019.05.051_bib43","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00431-011-1455-0","article-title":"Neonatal hepatoblastoma in a newborn with severe phenotype of Beckwith-Wiedemann syndrome","volume":"170","author":"Mussa","year":"2011","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jpeds.2019.05.051_bib44","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00247-014-3000-6","article-title":"Relapse surveillance in AFP-positive hepatoblastoma: re-evaluating the role of imaging","volume":"44","author":"Rojas","year":"2014","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jpeds.2019.05.051_bib45","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MPH.0000000000000129","article-title":"Hepatoblastoma in children with Beckwith-Wiedemann syndrome: does it warrant different treatment?","volume":"36","author":"Trobaugh-Lotrario","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2019.05.051_bib46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1309\/AJCPN5BMTSF1CDYP","article-title":"Establishing reference intervals for clinical laboratory test results: is there a better way?","volume":"133","author":"Katayev","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jpeds.2019.05.051_bib47","doi-asserted-by":"crossref","first-page":"e27492","DOI":"10.1002\/pbc.27492","article-title":"Defining an optimal time window to screen for hepatoblastoma in children with Beckwith-Wiedemann syndrome","volume":"66","author":"Mussa","year":"2019","journal-title":"Pediatr Blood Cancer"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347619306687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347619306687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:02:03Z","timestamp":1758358923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347619306687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":47,"alternative-id":["S0022347619306687"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2019.05.051","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of the Serum \u03b1-Fetoprotein Reference Range in Patients with Beckwith-Wiedemann Spectrum","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2019.05.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}